Melanoma Research Victoria

Source: OncLive, March 2019 Ryan J. Sullivan, MD, instructor of Medicine, Harvard Medical School, assistant in medicine, MGH Cancer Center, Massachusetts General Hospital, discusses considerations for initial treatment of patients with metastatic melanoma. There are several different factors for physicians to take into consideration before deciding on a treatment strategy, Sullivan says. First and foremost, […]

Read the full story

Source: Cancer Therapy Advisor, March 2019 The ecology of immune cell populations within tumor microenvironments importantly contributes to tumor responses to immunotherapy but the details of these interactions are not yet completely understood. Using RNA sequencing data, authors of a study published in Cell report that many CD8+ T cells in the melanoma microenvironment are becoming progressively […]

Read the full story

Source: Science in Poland, March 2019 As part of a grant from the Sonata Bis competition financed by the National Science Centre, the biochemist from the Department of Cell Pathology at the University of Wroc?aw focuses on the role of gelsolin in the migration and adhesion of normal cells, including melanocytes and Schwann cells, as […]

Read the full story

Source: MdLinx, March 2019 In this prospective study, researchers assessed the effectiveness of both regular clinical examination and ultrasound surveillance of regional lymph node basins in patients with intermediate-thickness cutaneous melanoma. They recruited 90 patients with melanoma with a 1.2–3.5 mm thickness who had under-gone wide local excision but not sentinel node biopsy to a […]

Read the full story